Endotoxin Activity Assay as a Novel Predictor of Disease Progression in Patients With Mild Cholangitis

KOICHI MORI; KENTARO MIYAKE; RYUSEI MATSUYAMA; KOKI GOTO; SAYAKA ARISAKA; YUSUKE SUWA; TOSHIAKI KADOKURA; YUKI HOMMA; ITARU ENDO

doi:10.21873/invivo.13970

Article Information

vol. 39 no. 3 1685-1693

DOI

https://doi.org/10.21873/invivo.13970

PMID

40294996

Published By

International Institute of Anticancer Research

Print ISSN

0258-851X

Online ISSN

1791-7549

History

Received February 16, 2025
Revision received March 4, 2025
Accepted March 5, 2025
Published online April 28, 2025.

Copyright © 2025 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

KOICHI MORI ^#,
KENTARO MIYAKE ⇑^#,
RYUSEI MATSUYAMA,
KOKI GOTO,
SAYAKA ARISAKA,
YUSUKE SUWA,
TOSHIAKI KADOKURA,
YUKI HOMMA and
ITARU ENDO

Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Kentaro Miyake (ORCID: 0000-0002-4680-4317), MD, Ph.D., Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, 3-9 Fukuura Kanazawa-ku Yokohama-shi, Kanagawa, 236-0024, Japan. E-mail: kmkmkm{at}yokohama-cu.ac.jp